Quoin Pharmaceuticals, Ltd. (QNRX)

NCM – Цена в реальном времени. Валюта: USD

5.76

+0.56 (10.62%)

Рынок открыт: Aug 12, 2026, 3:07 PM EDT

5.12

-0.23 (-4.31%)

Предыдущая сессия: Aug 11, 2026, 5:10 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

07.08.2026

Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026

ASHBURN, Va., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to provide a corporate update and release its financial results for the second quarter ended June 30, 2026, before the market opens on Friday, August 14, 2026.

Видео

No Data

There is no data to display

Quoin Pharmaceuticals, Ltd. (QNRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026

Видео

No Data

Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026

Видео

No Data

Search stocks

Quoin Pharmaceuticals, Ltd. (QNRX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Quoin Pharmaceuticals, Ltd. (QNRX)

Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026

Видео

No Data

Quoin Pharmaceuticals to Announce Corporate Update and Second Quarter 2026 Financial Results on Friday, August 14, 2026

Видео

No Data